Seattle, Washington Clinical Trials

A listing of Seattle, Washington clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 70 clinical trials
A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. It is the most common form of lung cancer, accounting for around 85% of lung cancers. The purpose of this study is to evaluate the safety and efficacy …

lung cancer
non-small cell lung cancer
metastatic nsclc
pd-l1
measurable disease
Swedish Cancer Institute /ID# 216915
 (0.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +38 other locations
Decitabine With Ruxolitinib or Fedratinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

This phase II trial studies how well decitabine with ruxolitinib or fedratinib works before hematopoietic stem cell transplant in treating patients with accelerated/blast phase myeloproliferative neoplasms (tumors). Drugs used in chemotherapy, such as decitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, …

mds/mpd
hydroxyurea
chronic myeloproliferative disease
bone marrow procedure
blood cell count
Fred Hutch/University of Washington Cancer Consortium
 (1.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of AK104 a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

This is a Phase 2, global, multicenter, open label, single arm study designed to evaluate the efficacy, safety, tolerability, pharmacokinetic (PK), and immunogenicity of AK104 monotherapy in adult subjects with previously treated recurrent or metastatic cervical carcinoma.

bevacizumab
prednisone
pd-l1
cervical carcinoma
cancer treatment
Pacific Gynecology Specialists, P. C.
 (0.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +19 other locations
Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults Adolescents and Pediatrics

The purpose of this study is to demonstrate the performance of the Disposable Sensor (DS5) in subjects age 2 - 80 years, for the span of 170 hours (7 days).

type 2 diabetes mellitus
diabetes
type 1 diabetes mellitus
insulin
insulin sensitivity
Rainier Clinical Research Center, Inc.
 (9.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +12 other locations
Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax

This study will find out whether people with CLL or SLL who have received treatment with venetoclax, either alone or in combination with another drug, and who are found to be MRD-negative, can stop treatment with venetoclax and remain off-treatment for 12 months or more. The researchers will also see …

residual tumor
lymphoid leukemia
lymphoma
venetoclax
monoclonal protein
Fred Hutchinson Cancer Research Center
 (1.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
THE ALIGN-AR PIVOTAL TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

To collect information about treatment for symptomatic severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allows some blood to leak back into the heart chamber. Symptoms of aortic regurgitation may …

regurgitation
shortness of breath
aortic valve replacement
fatigue
University of Washington
 (3.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

This is a phase I, open-label, non-randomized study that will enroll pediatric and young adult research participants with relapsed or refractory non-CNS solid tumors to evaluate the safety, feasibility, and efficacy of administering T cell products derived from the research participant's blood that have been genetically modified to express a …

biologic therapy
recurrent disease
mibg
cytokine release syndrome
trastuzumab
Seattle Children's Hospital
 (4.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

modafinil
genetic testing
methyldopa
resting tremor
datscan
Univ of Washington and VA Puget Sound Health Care System
 (0.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +45 other locations
ImmuneRACE - Immune Response Action to COVID-19 Events

ImmuneRACE is a study, which is designed to better understand the immune response to COVID-19. This is critically important because the immune system may be able to tell us important information about how our own bodies detect and respond to the disease that current tests cannot. De-identified data collected from …

coronavirus infection
oropharyngeal
Adaptive Biotechnologies
 (2.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
VENOUS: A Translational Study of Enterococcal Bacteremia

The purpose of this study is to assemble a multicenter prospective cohort of patients with enterococcal bloodstream infections (BSIs) to provide data on outcomes of patients with enterococcal BSIs for sample size calculations for future trials, as well as to characterize enterococcal isolates causing BSIs in order to comprehensively dissect …

Fred Hutchinson Cancer Research Center
 (1.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +11 other locations